0001859061-23-000006.txt : 20230517 0001859061-23-000006.hdr.sgml : 20230517 20230517071318 ACCESSION NUMBER: 0001859061-23-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230512 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: A2A Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001859061 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40335 FILM NUMBER: 23929618 BUSINESS ADDRESS: STREET 1: 59 5TH AVE CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: (914) 841-8818 MAIL ADDRESS: STREET 1: 59 5TH AVE CITY: NEW YORK STATE: NY ZIP: 10003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biomea Fusion, Inc. CENTRAL INDEX KEY: 0001840439 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 MIDDLEFIELD ROAD STREET 2: 4TH FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: (650) 980-9099 MAIL ADDRESS: STREET 1: 900 MIDDLEFIELD ROAD STREET 2: 4TH FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 primary_doc.xml PRIMARY DOCUMENT X0407 4 2023-05-12 0 0001840439 Biomea Fusion, Inc. BMEA 0001859061 A2A Pharmaceuticals, Inc. 59 5TH AVE NEW YORK NY 10003 0 0 1 0 0 Common Stock 2023-05-12 2023-05-12 4 S 0 25000 33.84 D 3625000 D A total of 25,000 shares were sold at an average price of 33.84 in multiple transactions in a range of 33.50 to 34.50. Details of the specific transactions are available upon request. Edward Painter 2023-05-17